MEDICAL LINEAR ACCELERATOR MARKET SIZE TO CROSS USD 2.2 BILLION BY 2020, GROWING AT A CAGR OF 7% DURING THE FORECAST PERIOD

Medical Linear Accelerator Market Size, Share, & Trends Analysis Report by Products (equipment and software), Application (breast, prostate, lung, head and neck, colorectal cancer and others), End-users (hospitals, cancer care centers, and academic institutes and research centers), and Geography (North America, APAC, Europe, Latin America, and MEA) Industry Analysis Report, Regional Outlook, Price Trends, Competitive Market Share, Growth Potential & Forecast, 2020 – 2025

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

233 Pages

icon-table

35 Tables

icon-chart

161 Charts

icon-region

5 Regions

icon-country

18 Countries

icon-company

6 Companies

icon-market

4 Market Segment

MEDICAL LINEAR ACCELERATORS MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (REVENUE) USD 2.2 BILLION (2025)
CAGR 7% (2020-2025)
BASE YEAR 2019
FOECAST YEAR 2020-2025
MARKET SEGMENTS Products (equipment and software), Application (breast, prostate, lung, head and neck, colorectal cancer and others), End-users (hospitals, cancer care centers, and academic institutes and research centers)
GEOGRAPHIC ANALYSIS North America, APAC, Europe, Latin America, and MEA
COUNTRIES COVERED US, Canada, Japan, China, South Korea, Australia, India, Germany, France, UK, Spain, Italy, Brazil, Mexico, Argentina, Turkey, Saudi Arabia and UAE

INDUSTRY INSIGHTS

The growing prevalence of cancer worldwide, coupled with rapid technological advancements and increased healthcare expenditure, is expected to boost the market growth. Linear accelerators (LINAC) are considered as breakthrough devices, which have revolutionized treatment due to their cost-effectiveness. Further, the market has witnessed a significant shift in cancer treatment delivery with increasing preference from invasive to non-invasive treatment procedures. As non-invasive treatment includes radiation therapy, which is the most advanced and cost-effective treatment option for patients. Therefore, this phenomenal shift in consumer expectation has increased the acceptance of medical LINAC equipment.
The market has witnessed significant growth in terms of sales volume, especially due to the growing prevalence of cancer and increasing demand for non-invasive cancer treatment. Globally, the prevalence of cancer is increasing at an alarming rate due to changing lifestyles, aging population, environmental pollution, and increasing smokers. It is one of the leading causes of high mortality rate across the world.

The emergence of artificial intelligence is revolutionizing the medical imaging devices market. Advances in machine learning (ML) and artificial intelligence (AI) are rapidly transforming cancer treatment using LINAC devices. Hence, vendors are focusing on developing AI and ML-enabled LINACs for oncology treatment, which is likely to become convenient treatment options in upcoming years.

SNIPPETS

  • The equipment segment is dominating the global market and accounted for a share of 80% during the forecast period
  • The North America region is leading the global medical linac market followed by Europe and APAC
  • The prostate cancer application segment is expected to witness the highest CAGR of 8.5%
  • In 2019, China accounted for a share of around 27% of the APAC region. The region has the highest incidence of cancer cases in APAC.
  • The breast cancer segment is expected to witness the highest incremental growth of over $270 million during the forecast period.

MEDICAL LINEAR ACCELERATOR MARKET SEGMENTATION

This research report includes detailed segmentation by

  • Product
  • Application
  • End-user
  • Geography

APPLICATION INSIGHTS

In 2019, breast cancer application segment accounted for 22% share of the global market. The segment is growing at a healthy with a CAGR of 8%. The rapid use of radiotherapy with medical linear accelerator equipment for the treatment of breast cancer, along with the growing incidence of these cases, is responsible for the segment growth.

The prostate segment is likely to grow at a promising CAGR during the forecast period. The segment is growing at a faster rate compared to other application segment and the trend is likely to continue during the forecast period. The primary factor driving growth includes the rise in prostate cancer worldwide. Further, the rise in the geriatric population worldwide is another key factor driving the market. Lung cancer treatment is projected to achieve maximum revenue owing to the rapid rise across the globe. Hence, the application of radiation therapy with LINAC for these treatments is likely to gain a lucrative share in the market.

PRODUCT INSIGHTS

The equipment segment is growing due to the growing incidence of cancers globally and the segment is expected to grow with the highest CAGR of 8.4% than software segment.

Key Advantages of Equipment

  • Shorter treatment schedules
  • Offers painless treatment
  • Higher speed and precision compared to other available treatments
  • Causes minimal damage to surrounding tissue

The use of innovative oncology informatics platforms has led to rapid progress in radiation treatment planning, thereby saving time and cost.

Key Advantages of LINAC Software

  • More timely and complete access to clinical and patient information
  • Easy sharing, analysing of information
  • Easier communication among HCPs and patients

END-USERS INSIGHTS

The hospital segment is likely to dominate the global medical linear accelerator market share. Healthcare professionals in hospitals are using LINACs as an advanced radiotherapy device for the treatment of cancer with a non-invasive procedure. The hospital segment is growing at a healthy rate and is likely to grow at a steady pace during the forecast period. The cancer care center segment is projected to grow at the highest CAGR during the forecast period. The segment will witness the highest incremental growth of around $550 million during the forecast period.

In 2019, the academic institute & research center end-users segment accounted for a 15% share of the global medical linear accelerator market. The segment is growing at a healthy rate. Moreover, the increasing number of cancer cases globally is another factor driving the growth of the segment.

GEOGRAPHICAL INSIGHTS

North America is growing at a significant rate due to the growing preference for technologically advanced medical LINAC devices. The region is expected to witness highest incremental growth of $420 million during the forecast period. The US is the major revenue contributor in the North America region.

Europe is the second largest market and accounted for a 32% share. Germany, France, the UK, Spain, and Italy are the major revenue contributors in Europe. The market is likely to grow at a steady rate due to the growing prevalence of cancer in Europe. Breast, colorectum, lung, prostate and bladder cancers were the most common cancer cases in 2018 in the region. Due to increasing burden of cancer patient population along with the need of advanced treatment procedures, many key players are focusing on launching innovative medical linear accelerator devices in the Europe. For instance, in June 2018, world's first high-field MR-linac, Elekta Unity received CE Mark, which created a huge interest from potential customers.

The APAC market is expected to witness the highest absolute growth during the forecast period. The region has the largest population density and the highest proportion of people with cancers. China, Japan, India, Australia, and South Korea are the major revenue contributors from the region. Brazil, Mexico, and Argentina are the major revenue contributors to the medical linear accelerator market in Latin America. Although the market is growing at a moderate rate, it offers tremendous growth opportunities. Therefore, the growing need for efficient and high-quality medical care is likely to drive the growth in Latin America. Turkey, Saudi Arabia, and South Africa are the major revenue contributors to the MEA region.

KEY VENDOR ANALYSIS

The global medical LINAC market has only six vendors that provide medical linear accelerator equipment at the global and regional levels. The market is highly consolidated as the leading two vendors account for around 89% of the share. The market is witnessing rapid technological advancements and product launches. Global players are focusing on developing innovative products and expanding their product portfolio to remain competitive in the industry. They are investing extensively in R&D and product development activities to expand their product portfolio.

The global medical linear accelerator market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

 By Products

  • Equipment
  • Oncology Informatics/Software

By Application 

  • Breast Cancer
  • Prostate Cancer
  • Lung Cancer
  • Head & Neck Cancer
  • Colorectal Cancer
  • Others

By End-users

  • Hospitals
  • Cancer Care Centers
  • Academic Institutes and Research Centers

By Geography

  • North America
    • US
    • Canada
  • APAC
    • Japan
    • China
    • South Korea
    • Australia
    • India
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • Turkey
    • Saudi Arabia
    • UAE

 

Frequently Asked Questions

What is the market size and CAGR of the medical linear accelerator market during the forecast period?

Medical linear accelerator market size to cross revenues of over USD 2.2 billion by 2020, growing at a CAGR of over 7% during the forecast period.

Which product/application/end-user/region is growing at the fastest CAGR during the forecast period?

The equipment segment is dominating the global market and accounted for a share of 80% during the forecast period.

How are the advancements in machine learning (ML) and artificial intelligence (AI) boosting the LINAC devices market growth?

The emergence of artificial intelligence is revolutionizing the medical imaging devices market. Advances in machine learning (ML) and artificial intelligence (AI) are rapidly transforming cancer treatment using LINAC devices. Hence, vendors are focusing on developing AI and ML-enabled LINACs for oncology treatment, which is likely to become convenient treatment options in upcoming years.

Who are the leading vendors in the market?

Varian Medical Systems, Elekta, and Accuray are the leading vendors.

Download Free Sample

The global medical linear accelerator market is growing at a CAGR of over 7% during the forecast period 2019–2025.

 The following factors are likely to contribute to the growth of the medical linear accelerator market during the forecast period:

  • High Prevalence of Cancers
  • Increasing Demand for Non-invasive Cancer Treatment
  • Emergence of MRI-based Linear Accelerators
  • High Popularity of Robotic-enabled Radiotherapy

 Base Year:                  2019

Forecast Year:           2020–2025

The study considers the present scenario of the medical linear accelerator market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply aspects of the market. The report profiles and examines leading companies and other prominent companies operating in the market.

Key Vendors

  • Varian Medical Systems
    • Business Overview
    • Major Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Elekta
  • Accuray

Other Prominent Vendors

  • SHINVA MEDICAL INSTRUMENT
    • Business Overview
    • Major Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Panacea Medical Technologies
  • ViewRay Technologies

 Market Segmentation by Products

  • Equipment
  • Oncology Informatics/Software

Market Segmentation by Application  

  • Breast Cancer
  • Prostate Cancer
  • Lung Cancer
  • Head & Neck Cancer
  • Colorectal Cancer
  • Others

Market Segmentation by End-users

  • Hospitals
  • Cancer Care Centers
  • Academic Institutes and Research Centers

Market Segmentation by Geography

  • North America
    • US
    • Canada
  • APAC
    • Japan
    • China
    • South Korea
    • Australia
    • India
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • Turkey
    • Saudi Arabia
    • UAE

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage

4.1 Market Definition

4.1.1 Inclusions

4.1.2 Exclusions

4.2 Base Year

4.3 Scope of the study

4.4 Market Segments

4.4.1 Market Segmentation by Products

4.4.2 Market Segmentation by Applications

4.4.3 Market Segmentation by End-users Type

4.4.4 Market Segmentation by Geography

5 Report Assumptions & Caveats

5.1 Key Caveats

5.2 Currency Conversion

5.3 Market Derivation

6 Market at a Glance

7 Introduction

7.1 Cancer: An Overview

7.1.1 Background

7.1.2 Radiotherapy

7.2 Medical LINACs

8 Market Dynamics

8.1 Market Growth Enablers

8.1.1 Growing Prevalence of Cancer

8.1.2 Technological Advances/Innovations

8.1.3 Increasing Demand for Non-Invasive Cancer Treatment

8.2 Market Growth Restraints

8.2.1 High Costs of LINACs

8.2.2 Lack of Infrastructure & Skilled Professionals

8.2.3 Alternate Treatment Options for Cancer

8.2.4 Risks and Complications Associated with RT

8.3 Market Opportunities and Trends

8.3.1 Product Approvals/Launches

8.3.2 Emergence of MRI-Based LINACs

8.3.3 Growing Popularity of Robotic Radiotherapy

8.3.4 Integration of AI in LINACs

9 Global Medical Linear Accelerator Market

9.1 Market Overview

9.2 Market Size & Forecast

9.3 Five Forces Analysis

9.3.1 Threat of New Entrants

9.3.2 Bargaining Power of Suppliers

9.3.3 Bargaining Power of Buyers

9.3.4 Threat of Substitutes

9.3.5 Competitive Rivalry

10 Medical Linear Accelerator Market by Product Type

10.1 Market Snapshot & Growth Engine

10.2 Market Overview

10.3 Equipment

10.3.1 Market Overview

10.3.2 Market Size & Forecast

10.4 Software

10.4.1 Market Overview

10.4.2 Market Size & Forecast

11 Medical Linear Accelerator Market by Application

11.1 Market Snapshot & Growth Engine

11.2 Market Overview

11.3 Breast Cancer

11.3.1 Market Overview

11.3.2 Market Size & Forecast

11.4 Prostate Cancer

11.4.1 Market Overview

11.4.2 Market Size & Forecast

11.5 Lung Cancer

11.5.1 Market Overview

11.5.2 Market Size & Forecast

11.6 Head & Neck Cancer

11.6.1 Market Overview

11.6.2 Market Size & Forecast

11.7 Colorectal Cancer

11.7.1 Market Overview

11.7.2 Market Size & Forecast

11.8 Others

11.8.1 Market Overview

11.8.2 Market Size & Forecast

12 Medical Linear Accelerator Market by End-Users

12.1 Market Snapshot & Growth Engine

12.2 Market Overview

12.3 Hospitals

12.3.1 Market Overview

12.3.2 Market Size & Forecast

12.4 Cancer Care Centers

12.4.1 Market Overview

12.4.2 Market Size & Forecast

12.5 Academic Institutes & Research Centers

12.5.1 Market Overview

12.5.2 Market Size & Forecast

13 Medical Linear Accelerator Market by Geography

13.1 Market Snapshot & Growth Engine

13.2 Overview

14 North America

14.1 Market Overview

14.2 Market Size & Forecast

14.3 Key Countries

14.3.1 US: Medical Linear Accelerator Market Size & Forecast

14.3.2 Canada: Market Size & Forecast

15 Europe

15.1 Market Overview

15.2 Market Size & Forecast

15.3 Key Countries

15.3.1 Germany: Market Size & Forecast

15.3.2 UK: Medical Linear Accelerator Market Size & Forecast

15.3.3 Italy: Market Size & Forecast

15.3.4 France: Market Size & Forecast

15.3.5 Spain: Market Size & Forecast

16 APAC

16.1 Market Overview

16.2 Market Size & Forecast

16.3 Key Countries

16.3.1 China: Medical Linear Accelerator Market Size & Forecast

16.3.2 Japan: Market Size & Forecast

16.3.3 India: Market Size & Forecast

16.3.4 Australia: Market Size & Forecast

16.3.5 South Korea: Market Size & Forecast

17 Latin America

17.1 Market Overview

17.2 Market Size & Forecast

17.3 Key Countries

17.3.1 Brazil: Medical Linear Accelerator Market Size & Forecast

17.3.2 Mexico: Market Size & Forecast

17.3.3 Argentina: Market Size & Forecast

18 Middle East & Africa

18.1 Market Overview

18.2 Market Size & Forecast

18.3 Key Countries

18.3.1 Turkey: Medical Linear Accelerator Market Size & Forecast

18.3.2 Saudi Arabia: Market Size & Forecast

18.3.3 South Africa: Market Size & Forecast

19 Competitive Landscape

19.1 Competition Overview

19.2 Market Share Analysis

19.2.1 Varian Medical Systems

19.2.2 Elekta

19.2.3 Accuray

19.2.4 VIEWRAY

19.2.5 SHINVA MEDICAL INSTRUMENT

19.2.6 Panacea Medical Technologies

20 Key Vendors

20.1 Varian Medical Systems

20.1.1 Business Overview

20.1.2 Major Product Offerings

20.1.3 Key Strengths

20.1.4 Key Strategies

20.1.5 Key Opportunities

20.2 Elekta

20.2.1 Business Overview

20.2.2 Major Product Offerings

20.2.3 Key Strengths

20.2.4 Key Strategies

20.2.5 Key Opportunities

20.3 Accuray

20.3.1 Business Overview

20.3.2 Major Product Offerings

20.3.3 Key Strengths

20.3.4 Key Strategies

20.3.5 Key Opportunities

21 Other Prominent Vendors

21.1 SHINVA MEDICAL INSTRUMENT

21.1.1 Business Overview

21.1.2 Major Product Offerings

21.1.3 Key Strengths

21.1.4 Key Strategies

21.1.5 Key Opportunities

21.2 Panacea Medical Technologies

21.2.1 Business Overview

21.2.2 Major Product Offerings

21.2.3 Key Strengths

21.2.4 Key Strategies

21.2.5 Key Opportunities

21.3 VIEWRAY TECHNOLOGIES

21.3.1 Business Overview

21.3.2 Major Product Offerings

21.3.3 Key Strengths

21.3.4 Key Strategies

21.3.5 Key Opportunities

22 Report Summary

22.1 Key Takeaways

22.2 Strategic Recommendations

22.3 Quantitative Summary

22.3.1 By Product

22.3.2 By Application

22.3.3 By End-users

22.3.4 By Geography

23 Appendix

23.1 Abbreviations

List of Exhibits 

Exhibit 1               Segmentation of Global Medical Linear Accelerator Market

Exhibit 2               Market Size Calculation Approach 2019

Exhibit 3               Impact of Growing Prevalence of Cancer

Exhibit 4               Global New Cancer Cases 2018 (% share)

Exhibit 5               Cancer Incidence: Segmentation by Geography 2018 (% share)

Exhibit 6               Impact of Technological Advance/Innovations

Exhibit 7               Impact of Increasing Demand for Non-Invasive Cancer Treatment

Exhibit 8               Cost Comparison of Various Cancer Treatments ($ thousands)

Exhibit 9               Global Market Opportunity for Medical LINACs

Exhibit 10             Impact of High Costs of LINACs

Exhibit 11             Impact of Lack of Infrastructure & Skilled Professionals

Exhibit 12             Distribution of Megavoltage Systems by Geography ($ share)

Exhibit 13             RT Units by Geography (per million population)

Exhibit 14             Alternate Treatment Options for Cancer

Exhibit 15             Common Side Effects of RT

Exhibit 16             Impact of Risks and Complications Associated with RT

Exhibit 17             Impact of Product Approvals/Launches

Exhibit 18             Impact of Emergence of MRI-based LINACs

Exhibit 19             Impact of Growing Popularity of Robotic Radiotherapy

Exhibit 20             Impact of Integration of AI in LINACs

Exhibit 21             Benefits of AI in LINACs

Exhibit 22             Global Medical Linear Accelerator Market: Opportunities Snapshot

Exhibit 23             Global Medical Linear Accelerator Market 2019−2025 ($ million)

Exhibit 24             Global Medical Linear Accelerator Market by Geography

Exhibit 25             Global Medical Linear Accelerator Market by Product Type

Exhibit 26             Global Medical Linear Accelerator Market by Application

Exhibit 27             Global Medical Linear Accelerator Market by End-users

Exhibit 28             Five Force Analysis 2019

Exhibit 29             Incremental Growth by Product Type 2019-2025

Exhibit 30             Market by Product Type

Exhibit 31             Market by Product: Incremental Growth

Exhibit 32             Market by Product: Absolute Growth

Exhibit 33             Market by Product 2019 & 2025 (%)

Exhibit 34             Market by Product Type 2019−2025 ($ million)

Exhibit 35             Market by Product Type 2019−2025 (% share)

Exhibit 36             Market by Equipment: Absolute & Incremental Growth

Exhibit 37             Global New Cancer Cases 2018

Exhibit 38             Global Medical Linear Accelerator Equipment Market 2019−2025 ($ million)

Exhibit 39             Global Medical Linear Accelerator Market by Software: Absolute & Incremental Growth

Exhibit 40             Global Medical Linear Accelerator Software Market 2019−2025 ($ million)

Exhibit 41             Incremental Growth by Application 2019-2025

Exhibit 42             Market by Applications

Exhibit 43             Market by Applications: Incremental Growth

Exhibit 44             Market by Applications: Absolute Growth

Exhibit 45             Market by Applications 2019 & 2025 (% share)

Exhibit 46             Market by Applications 2019−2025 ($ million)

Exhibit 47             Market by Applications 2019−2025 (% share)

Exhibit 48             Market by Breast Cancer: Absolute & Incremental Growth

Exhibit 49             Breast Cancer in Key Countries 2018 (Age Standardized Rate Per 100,000 Population)

Exhibit 50             Breast Cancer Incidence Rate: Geography 2018

Exhibit 51             Market by Breast Cancer 2019−2025 ($ million)

Exhibit 52             Market by Prostate Cancer: Absolute & Incremental Growth

Exhibit 53             Global Prostate Cancer: Age-standardized Rate per 100,000 Population 2018

Exhibit 54             Prostate Cancer Incidence: Segmentation by Geography 2018

Exhibit 55             Market by Prostate Cancer 2019−2025 ($ million)

Exhibit 56             Market by Lung Cancer: Absolute & Incremental Growth

Exhibit 57             Lung Cancer Incidence: Segmentation by Geography 2018

Exhibit 58             Market by Lung Cancer 2019−2025 ($ million)

Exhibit 59             Market by Head and Neck Cancer: Absolute & Incremental Growth

Exhibit 60             Market by Head & Neck Cancer 2019−2025 ($ million)

Exhibit 61             Market by Colorectal Cancer: Absolute & Incremental Growth

Exhibit 62             Colorectal Cancer Incidence Rate by Geography 2018

Exhibit 63             Market by Colorectal Cancer 2019−2025 ($ million)

Exhibit 64             Market by Other Cancers: Absolute & Incremental Growth

Exhibit 65             Global Newly Diagnosed Cancer Cases 2018

Exhibit 66             Market by Other Cancers 2019−2025 ($ million)

Exhibit 67             Incremental Growth by End-users 2019-2025

Exhibit 68             Global Medical LINACs Market by End-users

Exhibit 69             Market by End-users: Absolute Growth

Exhibit 70             Market by End-users: Incremental Growth

Exhibit 71             Market by End-users 2019 & 2025 (% share)

Exhibit 72             Market by End-users 2019−2025 ($ million)

Exhibit 73             Market by End-Users 2019−2025 (% share)

Exhibit 74             Market by Hospitals: Absolute & Incremental Growth

Exhibit 75             Market by Hospitals 2019−2025 ($ million)

Exhibit 76             Market by Cancer Care Centers: Absolute & Incremental Growth

Exhibit 77             Market by Cancer Care Centers 2019−2025 ($ million)

Exhibit 78             Market by Academic Institutes & Research Centers: Absolute & Incremental Growth

Exhibit 79             Market by Academic Institutes & Research Centers 2019−2025 ($ million)

Exhibit 80             Incremental Growth by Geography 2019-2025

Exhibit 81             Global Medical LINACs Market by Geography

Exhibit 82             Market by Geography 2019 ($ million)

Exhibit 83             Market by Geography: Absolute Growth

Exhibit 84             Market by Geography: Incremental Growth

Exhibit 85             Market by Geography 2019 & 2025 (%)

Exhibit 86             Market by Geography 2019−2025 ($ million)

Exhibit 87             Market by Geography 2019−2025 (%)

Exhibit 88             Medical Linear Accelerator Market in North America: Key Countries 2019

Exhibit 89             Market in North America: Absolute & Incremental Growth

Exhibit 90             New Cancer Cases in North America 2018

Exhibit 91             Market in North America 2019−2025 ($ million)

Exhibit 92             Incremental Growth in North America 2019−2025

Exhibit 93             Number of New Cancer Cases in US 2018

Exhibit 94             Market in US 2019−2025 ($ million)

Exhibit 95             New Cancer Cases in Canada 2018

Exhibit 96             Market in Canada 2019−2025 ($ million)

Exhibit 97             Medical LINACs Market in Europe: Key Countries 2019

Exhibit 98             Europe Medical Linear Accelerator Market: Absolute & Incremental Growth

Exhibit 99             Number of New Cancer Cases in Europe 2018

Exhibit 100          Number of New Cancer Cases in Men in Europe 2018

Exhibit 101          Number of New Cancer Cases in Women in Europe 2018

Exhibit 102          Market in Europe 2019–2025 ($ million)

Exhibit 103          Incremental Growth in Europe 2019-2025

Exhibit 104          Number of New Cancer Cases in Men & Women 2018

Exhibit 105          Market in Germany 2019–2025 ($ million)

Exhibit 106          Number of New Cancer Cases in UK 2018

Exhibit 107          Market in UK 2019–2025 ($ million)

Exhibit 108          Number of New Cancer Cases in Ital 2018

Exhibit 109          Market in Italy 2019–2025 ($ million)

Exhibit 110          Number of New Cancer Cases in France 2018

Exhibit 111          Market in France 2019–2025 ($ million)

Exhibit 112          Number of New Cancer Cases in Spain 2018

Exhibit 113          Market in Spain 2019–2025 ($ million)

Exhibit 114          Medical Linear Accelerator Market in APAC: Key Countries 2019

Exhibit 115          Market in APAC: Absolute & Incremental Growth

Exhibit 116          Number of New Cancer Cases in APAC 2018

Exhibit 117          Number of New Cancer Cases in APAC in Men 2018

Exhibit 118          Number of New Cancer Cases in APAC in Women 2018

Exhibit 119          Market in APAC 2019–2025 ($ million)

Exhibit 120          Incremental Growth in APAC 2019-2025

Exhibit 121          New cancer Cases in China 218

Exhibit 122          Market in China 2019–2025 ($ million)

Exhibit 123          New Cancer Cases in Japan 2018

Exhibit 124          Market in Japan 2019–2025 ($ million)

Exhibit 125          Number of New Cancer Cases in India 2018

Exhibit 126          Market in India 2019–2025 ($ million)

Exhibit 127          Number of New Cancer Cases in Australia 2018

Exhibit 128          Market in Australia 2019–2025 ($ million)

Exhibit 129          Number of New Cancer Cases in Korea 2018

Exhibit 130          Market in South Korea 2019–2025 ($ million)

Exhibit 131          Medical Linear Accelerator Market in Latin America: Key Countries 2019

Exhibit 132          Market in Latin America: Absolute & Incremental Growth

Exhibit 133          Number of New Cancer Cases in Latin America 2018

Exhibit 134          Number of New Cancer Cases in Latin America in Men 2018

Exhibit 135          Number of New Cancer Cases in Latin America in Women 2018

Exhibit 136          Market in Latin America 2019–2025 ($ million)

Exhibit 137          Incremental Growth in Latin America 2019-2025

Exhibit 138          Number of New Cancer cases in Brazil 2018

Exhibit 139          Market in Brazil 2019–2025 ($ million)

Exhibit 140          Number of New Cancer Cases in Mexico 2018

Exhibit 141          Market in Mexico 2019–2025 ($ million)

Exhibit 142          Number of New Cancer Cases in Argentina 2018

Exhibit 143          Market in Argentina 2019–2025 ($ million)

Exhibit 144          Medical Linear Accelerator Market in MEA 2019

Exhibit 145          Market in MEA: Absolute & Incremental Growth

Exhibit 146          Number of New Cancer Cases in Africa 2018

Exhibit 147          Market in MEA 2019–2025 ($ million)

Exhibit 148          Incremental Growth in MEA 2019-2025

Exhibit 149          Number of New Cancer Cases in Turkey 2018

Exhibit 150          Market in Turkey 2019–2025 ($ million)

Exhibit 151          Number of New Cancer Cases in Saudi Arabia 2018

Exhibit 152          Market in Saudi Arabia 2019–2025 ($ million)

Exhibit 153          Number of New Cancer Cases in South Africa 2018

Exhibit 154          Market in South Africa 2019–2025 ($ million)

Exhibit 155          Global Medical Linear Accelerators Market: Key Vendors (% share)

Exhibit 156          Varian Medical Systems: R&D Expenditure 2016−2018 ($ million)

Exhibit 157          Varian Medical Systems: Revenue by Segments

Exhibit 158          Elekta: Revenue by Geography

Exhibit 159          Elekta: R&D Expenditure 2017−2019 ($ million)

Exhibit 160          Elekta: Revenue Breakdown by Geography

Exhibit 161          Accuray: Revenue Breakdown by Geography FY2019 (% share)

               

List of Tables    

Table 1                  Key Caveats

Table 2                  Currency Conversion 2013−2018

Table 3                  Technologically Advanced Medical LINACs by Key Players

Table 4                  Approximate Cost of LINAC Systems

Table 5                  Average Procedural Cost of Lung Cancer Radiotherapy with SBRT ($ thousands)

Table 6                  Global Estimated Trends in Cancer Incidence 2010-2030

Table 7                  Crude Cancer Incidence in LMICs

Table 8                  Key Advantages of Other Available Treatment Options for Cancer

Table 9                  Treatment Areas and Possible Side-effects of RT

Table 10               Recent Product Approvals and Launches in Global Medical Linear Accelerator Market

Table 11               Medical LINACs from Key Market Players

Table 12               LINAC Compatible Software by Key Market Players

Table 13               LINACs for Breast Cancer by Players

Table 14               Medical LINAC for Prostate Cancer by Players

Table 15               Medical LINACs for Lung Cancer by Players

Table 16               Medical LINACs for Head & Neck Cancer by Players

Table 17               Prominent Cancer Care Centers Around the World

Table 18               Prominent Academic Institutes & Research Centers

Table 19               CMS Approved New Rates in US 2018

Table 20               Estimated Number of LINACs in Key European Countries

Table 21               Global Medical Linear Accelerator Market: Top Vendors Ranking

Table 22               Varian Medical Systems: Key Product Offerings

Table 23               Elekta: Key Product Offerings

Table 24               Accuray: Key Product Offerings

Table 25               SHINVA MEDICAL INSTRUMENT: Key Product Offerings

Table 26               Panacea Medical Technologies: Key Product Offerings

Table 27               VIEWRAY TECHNOLOGIES: Key Product Offerings

Table 28               Global Market by Products ($ million)

Table 29               Global Market by Products (% share)

Table 30               Global Market by Application ($ million)

Table 31               Global Market by Applications (% share)

Table 32               Global Market by End-users ($ million)

Table 33               Global Market by End-users (% share)

Table 34               Global Market by Geography ($ million)

Table 35               Global Market by Geography (% share)

Select a license type that suits your business needs

single-user Single User Licence
$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4000.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5000.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date